American Society of Hirudotherapy

Taxonomic update and DNA barcoding of Tunisian nasal leeches (Annelida: Hirudiniformes; Praobdellidae): confirming Limnatis nilotica and revealing a second Limnatis species in North Africa

Taxonomic study published in Invertebrate Systematics (2025)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomics & ProteomicsSafety & Infection ControlBen Ahmed R et al. · Invertebrate Systematics, 2025

Abstract

Leeches of the genus Limnatis are known ectoparasites of vertebrates, including humans and domestic animals, with some species causing significant health complications. In this study, we describe Limnatis anouarensis sp. nov., a new nasal leech species from Tunisia and compare it with Limnatis nilotica sensu stricto from Tunisia and Morocco. Morphological analyses were conducted using light and scanning electron microscopy, focusing on external and internal structures. Additionally, mitochondrial (cytochrome c oxidase subunit I, COI; 12S rRNA, 12S) and nuclear (28S rRNA, 28S) gene fragments were sequenced for molecular characterisation. The new species is distinguished by its larger size, distinct reproductive system morphology and unique dorsal colouration, characterised by a median orange band and marginal orange stripes, in contrast to the black-striped pattern of L. nilotica (Moore, 1938). Molecular analyses confirmed that mitochondrial markers provide reliable species identification, whereas the analysed fragment of 28S gene was fully conserved and unsuitable for differentiation. These findings confirm the presence of at least two distinct Limnatis species in North Africa, emphasising the need for further taxonomic and ecological studies to clarify their distribution, host specificity and potential medical significance. ZooBank: urn:lsid:zoobank.org:pub:7CA59D0E-1D42-4A02-B886-D198DD88E698.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsDNA Barcoding, TaxonomicLeechesTunisiaSpecies SpecificityPhylogenyAfrica, NorthernElectron Transport Complex IVRNA, Ribosomal, 28S

Summary

Describes Limnatis anouarensis sp. nov., a new North African nasal leech species (vertebrate ectoparasite causing public health complications) distinguished by morphology and mitochondrial COI/12S markers from Limnatis nilotica.

Why This Matters for Hirudotherapy

This taxonomic study describes Limnatis anouarensis sp. nov., a newly identified nasal leech species from Tunisia, and compares it morphologically and molecularly with Limnatis nilotica sensu stricto using light and scanning electron microscopy plus mitochondrial (COI, 12S) and nuclear (28S) DNA sequencing. The new species is distinguished by larger size, distinct reproductive system morphology, and unique dorsal coloration featuring a median orange band and marginal orange stripes versus the black-striped pattern of L. nilotica. While this study involves leeches, its focus is purely systematic; these are parasitic nasal leeches of vertebrates, not the medicinal leeches used in hirudotherapy. The findings have no direct relevance to therapeutic leech application or the leech secretome, and any noted medical significance relates to parasitic infestation rather than therapeutic use.

Citation

Taxonomic update and DNA barcoding of Tunisian nasal leeches (Annelida: Hirudiniformes; Praobdellidae): confirming Limnatis nilotica and revealing a second Limnatis species in North Africa.

Ben Ahmed R et al. · Invertebrate Systematics, 2025

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.